A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating ...

Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...

After a phase 3 study showed a promising pCR rate with HLX11, the pertuzumab biosimilar’s BLA has been accepted for review by the FDA.

A 58-year-old male patient presented to the dermatology clinic at West China Hospital of Sichuan University (Chengdu, Sichuan ...

Obstructive uropathy secondary to malignant ureteral strictures is rare, with carcinoma of the breast accounting for less ...

The BBC spoke to six people - including Erica, Jessica and Jack - who have had their first cervical screening in the last six months People not knowing about options to make their cervical ...

4 years have passed, and some high-income countries (eg, Australia, Sweden, and the UK) are on the threshold of attaining a cervical cancer incidence of four or fewer cases per 100 000 women-years.

Cervical cancer is increasing among rural Indian women, with many unaware of its symptoms or testing. Primarily caused by HPV, it can be detected through regular screening and prevented with ...

At the heart of the debate is the common breast cancer diagnosis DCIS, or ductal carcinoma in situ. The phrase ... esophagus, bladder, cervix, prostate and skin. Some, like early-stage prostate ...

High-risk HPVs cause cervical dysplasia and carcinoma in situ, which if locally confined can be successfully treated but if left untreated can progress to cervical carcinoma. There is usually a ...

This type of cancer starts in the squamous cells. Squamous cells line the cervix, and they can be damaged by HPV infection. Squamous cell carcinoma is the most common type of cervical cancer. The ...